AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
Categories
Health Care
Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission
Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the European Commission
COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge
Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one of the
Neogen Corp. (NEOG) Q2 2021 Earnings Call Transcript
Neogen Corp. (NASDAQ: NEOG) Q2 2021 earnings call dated Dec. 22, 2020 Corporate Participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
Rite Aid Corporation (RAD) Q3 2021 Earnings Call
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse — Senior Vice President, Investor Relations and
Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor Relations and
Infographic: Highlights of Rite Aid’s (RAD) Q3 2021 earnings report
Rite Aid Corporation (NYSE: RAD) reported a decline in third-quarter earnings, despite an increase in revenues, as margins were hurt by higher
Eli Lilly (LLY) is paving the way to a strong 2021
Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30% since the
Veru Inc. (VERU) Q4 2020 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q4 2020 earnings call dated Dec. 09, 2020. Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
One key stock you need to track ahead of COVID-19 vaccine approvals
It's been a spectacular year for many biotech and pharma investors who have made a killing out of the COVID-19 vaccine rally.
Is it time to book profits from Moderna?
Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the potential of
Alexion’s long-term prospects remain intact amid continued focus on rare diseases
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health conditions. The
Veeva Systems Inc. (VEEV) Q3 2021 Earnings Call Transcript
Veeva Systems Inc. (NYSE: VEEV) Q3 2021 earnings call dated Dec. 01, 2020 Corporate Participants: Ato Garrett -- Senior Director, Investor Relations Peter Gassner -- Founder,
AdaptHealth (AHCO) gains on AeroCare acquisition announcement
Shares of AdaptHealth Corp. (NASDAQ: AHCO) surged 15% in morning trade on Tuesday after the company announced its decision to acquire privately-held
China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Call Transcript
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations, The Foote
Is it the right time to invest in Agilent Technologies (A)?
Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown in the
Medtronic PLC (MDT) Q2 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2021 earnings call dated Nov. 24, 2020 Corporate Participants: Ryan Weispfenning -- Vice President - Head of Investor Relations
Infographic: How Medtronic (MDT) performed in Q2 financial results
Medtronic plc (NYSE: MDT) reported second quarter 2021 earnings results today. Worldwide revenue was $7.64 billion, down 0.8% on a reported basis
Agilent Technologies Inc. (A) Q4 2020 Earnings Call Transcript
Agilent Technologies Inc. (NYSE: A) Q4 2020 earnings call dated Nov. 23, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
COVID-19 vaccine: These pharma companies have also made headway
The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for the development
Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov
10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went public more